Lisa Maree Williams/Getty Images News
AstraZeneca (NASDAQ:AZN) on Thursday announced a $4.5B investment in a proposed manufacturing site in Virginia, $500M more than it initially planned, as the U.K.-based company becomes the latest pharma giant to expand its U.S. footprint amid the Trump administration’s tariff threats.
